Cancer Stem Cell News Volume 11.00 | Jan 5 2022

    0
    42






    2021-01-05 | CSCN 11.01


    Cancer Stem Cell News by STEMCELL Technologies
    Vol. 11.00 – 5 January, 2022
    TOP STORY

    The Scaffolding Protein DLG5 Promotes Glioblastoma Growth by Controling Sonic Hedgehog Signaling in Tumor Stem Cells

    DLG5 was upregulated in malignant gliomas compared to other solid tumors, being the predominant DLG member in all glioblastoma molecular subtypes. DLG5 promoted glioblastoma stem cell invasion, viability, and self-renewal.
    [Neuro-Oncology]

    Abstract

    Request your free copy of the 'Directed Differentiation of Pluripotent Stem Cells' Wallchart
    PUBLICATIONSRanked by the impact factor of the journal

    Novel Function of THEMIS2 in the Enhancement of Cancer Stemness and Chemoresistance by Releasing PTP1B from MET

    Scientists discovered an intrinsic signaling scaffold function of THEMIS2, which acted as a novel regulator of cancer stemness in promoting multiple cancer stemness properties including sphere formation, stemness markers expression, chemoresistance and tumorigenicity with low numbers of cancer cells implantation.
    [Oncogene]

    Abstract

    SP1-Induced lncRNA DUBR Promotes Stemness and Oxaliplatin Resistance of Hepatocellular Carcinoma via E2F1-CIP2A Feedback

    Investigators discovered a specificity protein 1-induced long noncoding RNA—DPPA2 upstream binding RNA (DUBR) and its high expression in hepatocellular carcinoma tissues and liver CSCs.
    [Cancer Letters]

    Abstract

    HIF1α/HIF2α Induces Glioma Cell Dedifferentiation into Cancer Stem Cells through Sox2 under Hypoxic Conditions

    Scientists performed a series of experiments to verify whether HIF1α, HIF2α and Sox2 regulated glioma cell dedifferentiation under hypoxic conditions. Sphere formation by single glioma cells was observed, and CD133 and CD15 expression was compared between the normoxic and hypoxic groups.
    [Journal of Cancer]

    Full Article

    Suppression of Stemness and Enhancement of Chemosensibility in the Resistant Melanoma Were Induced by Astragalus Polysaccharide through PD-L1 Downregulation

    Investigators established chemo-resistant melanoma cells and found that expression of stemness genes were upregulated in the resistant melanoma cells. And Astragalus polysaccharide could downregulate expression of stemness genes.
    [European Journal of Pharmacology]

    Abstract

    BIX-01294 Enhances the Effect of Chemotherapy on Colorectal Cancer by Inhibiting the Expression of Stemness Genes

    A small molecule EHMT-2 inhibitor, BIX-01294, was evaluated for its activity in inhibiting CSCs in human colorectal cancer by in vitro and in vivo experiments.
    [Biochemical and Biophysical Research Communications]

    Abstract

    CD44-Positive Cancer Stem Cells from Oral Squamous Cell Carcinoma Exhibit Reduced Proliferation and Stemness Gene Expression upon Adipogenic Induction

    Scientists assessed adipogenic differentiation and its effect on the proliferation and stemness markers in CD44+ oral squamous cell carcinoma (OSCC) CSCs. D44+ CSCs were sorted by magnetic sorting from the single-cell suspension of the OSCC tumor.
    [Medical Oncology]

    AbstractGraphical Abstract

    HPV16 E6 Promotes Cell Proliferation, Migration, and Invasion of Human Cervical Cancer Cells by Elevating Both EMT and Stemness Characteristics

    Human papilloma virus (HPV)16 E6 silence or overexpression were carried out to evaluate the possible mechanisms of HPV16 E6 function in cervical cancer cells with different HPV16 E6 expression background.
    [Cell Biology International]

    Abstract

    MACC1 Regulates the AKT/STAT3 Signaling Pathway to Induce Migration, Invasion, Cancer Stemness, and Suppress Apoptosis in Cervical Cancer Cells

    Researchers verified that treatment with the STAT3 activator had significant reversal effects on the malignant behaviors of cervical cancer (CC) cells and CC stemness.
    [Bioengineered]

    Full Article

    How to prioritize and manage your research projects
    REVIEWS

    EHMT1/EHMT2 in EMT, Cancer Stemness and Drug Resistance: Emerging Evidence and Mechanisms

    The authors discuss cancer-type specific molecular targets, context-dependent mechanisms and future directions of research in targeting EHMT1/EHMT2 for the treatment of cancer.
    [FEBS Journal]

    AbstractFull Article

    INDUSTRY AND POLICY NEWS

    Oncolyze Announces FDA Orphan Drug Designation for OM-301 for the Treatment of Acute Myeloid Leukemia

    Oncolyze, Inc, announced that the US FDA has granted the company orphan drug designation for its pipeline compound OM-301 for the treatment of acute myeloid leukemia. OM-301 is currently in pre-clinical development for AML and other cancers.
    [Oncolyze, Inc. (GlobeNewswire, Inc.)]

    Press Release

    FEATURED EVENT

    12th AACR-JCA Conference: Breakthroughs in Cancer Research

    February 5 – 9, 2022
    Maui, Hawaii, United States

    > See All Events

    JOB OPPORTUNITIES

    Postdoctoral Associate – Molecular and Cellular Biology

    Baylor College of Medicine – Houston, Texas, United States

    Laboratory Research Scientist – CRISPR-Based Genetic Methods

    Francis Crick Institute – London, England United Kingdom

    Clinical Research Manager – Leukemia Clinical Trials

    Dana-Farber Cancer Institute – Boston, Massachusetts, United States

    Professors – Synthetic Biology in Cancer Immunotherapy

    The University of Chicago – Chicago, Illinois, United States

    Staff Scientist/Research Associate – Cancer Research

    Fred Hutchinson Cancer Research Center – Seattle, Washington, United States

    > See All Jobs

    Submit an article, publication, job or event
    Brought to you by
    stemcell-logo-for newsletter-2
    Cancer Stem Cell News Twitter